Effects of tail fat on halothane biotransformation in fat-tailed sheep.
1. The aim of the present study was to evaluate the effects of tail fat on halothane biotransformation following similar anaesthetic exposure in intact sheep and sheep with a ligated median sacral artery. 2. A prospective randomized experimental study was performed using 12 healthy, 10-12-month-old female sheep. 3. Sheep were randomly divided into two groups of six animals each and were anaesthetized twice at 2 weekly intervals. After mask induction with halothane in 100% oxygen, sheep were intubated and anaesthesia was maintained for 3 h using a rebreathing system. Serum fluoride concentration (SFC) was measured at 0, 1, 3, 6, 12, 24, 48 and 72 h following the induction of anaesthesia. Serum biochemistry was also evaluated at baseline and 72 h after anaesthesia. Induction and extubation times and time to sternal recumbency were also recorded during anaesthetic induction and recovery. Prior to the second anaesthesia (2 weeks later), the median sacral artery (MSA) was ligated under epidural anaesthesia in the experimental group. Sheep in the control group underwent sham operation. All sheep were anaesthetized as before. 4. Following the first halothane anaesthesia, SFC was significantly increased from 3 to 48 h compared with baseline. In the second stage of the experiment, the increases in SFC in the control group were similar to those seen in the first stage of the experiment. However, in MSA-ligated sheep, the increases in SFC were only significant between 3 and 12 h compared with baseline. The SFC was significantly higher in intact sheep from 3 to 72 h compared with the MSA-ligated group. Extubation and sternal recumbency times were significantly longer in intact sheep. 5. Ligation of the MSA in fat-tailed sheep induced a significant reduction in SFC, suggesting that the presence of tail fat substantially affects halothane metabolism during the peri-anaesthetic period in sheep. The greater extent of halothane biotransformation may be clinically important in, otherwise normal, obese patients.
Sharifi
S
S
Department of Veterinary Clinical Science, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Vesal
N
N
D000280:Administration, Inhalation; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics; D000818:Animals; D001784:Blood Gas Analysis / Q000379:methods; D001831:Body Temperature / Q000187:drug effects; D005223:Fats / Q000378:metabolism*; D005260:Female; D005459:Fluorides / Q000097:blood; D006221:Halothane / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics*; D023421:Models, Animal; D011897:Random Allocation; D012445:Sacrococcygeal Region / Q000098:blood supply / Q000601:surgery; D012472:Salivation / Q000187:drug effects; D012756:Sheep; D013623:Tail / Q000378:metabolism*; D013997:Time Factors
D018685:Anesthetics, Inhalation; D005223:Fats; D005459:Fluorides; D006221:Halothane